Gene · 3003
NIH grants2,103
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,661 to 1,680 of 2,103
Download this page as JSON| Grant | Title | GZMK papers | Newest fiscal year |
|---|---|---|---|
| R01AI015608 | Cytotoxic T Lymphocyte Response to Influenza Virus | 1 | 2017 |
| R01AI050875 | Photodynamic Therapy of Localized Infections | 1 | 2017 |
| R01AI073450 | Modulation of Innate and Adaptive Immunity by Dengue Virus | 1 | 2017 |
| R01AI076066 | T cell functionality and control of HIV infection | 1 | 2017 |
| R01AI100879 | Lymphoid Tissue Inducer/NK22 Cells and Post-transplant Immune Recovery | 1 | 2017 |
| R01AI105343 | Cellular and transcriptional control of exhausted CD8 T cells lineage dynamics | 1 | 2017 |
| R01AI107625 | Mechanisms to diversify repertoire and modify T cell activity after infection | 1 | 2017 |
| R01AI111809 | Boosting cell-intrinsic innate immune recognition of HIV-1 by dendritic cells | 1 | 2017 |
| R01AI112493 | Learning from attenuated CMV how to broaden HIV-specific T cell responses | 1 | 2017 |
| R01AR063676 | Large-Scale Characterization of Autoantibody Responses in Rheumatoid Arthritis | 1 | 2017 |
| R01AR063910 | DBP and the bioavailability and function of vitamin D | 1 | 2017 |
| R01CA072669 | Cytotoxic-T-Lymphocyte (CTL) Therapy of AML | 1 | 2017 |
| R01CA115746 | Characterizing Prostate Cancer By ex vivo MRS Signatures | 1 | 2017 |
| R01CA154387 | Inhibiting serine protease-induced prostate cancer progression | 1 | 2017 |
| R01CA161018 | Mechanism of PIN development in Abi1/Hssh3bp1 KO mouse | 1 | 2017 |
| R01CA163722 | Defining mechanisms of extracellular communication for cancer therapy | 1 | 2017 |
| R01CA169172 | Inhibiting VHL-positive kidney cancer | 1 | 2017 |
| R01CA172603 | A novel strategy to identify prostate cancer biomarkers for patient management | 1 | 2017 |
| R01CA175061 | Costimulatory mechanisms of antitumor Th17 cell immunity | 1 | 2017 |
| R01GM109199 | Functional Profiling of Human Disease Targets | 1 | 2017 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/grants?page=84